DynaMedex Disease and Condition Content Surpasses UpToDate in Quality & Comprehensiveness

By Maria Kingston.
Updated Jan 11, 2023

IPSWICH, Mass. (PRWEB) January 11, 2023 - DynaMedex from EBSCO Information Services (EBSCO) has achieved a new scale for breadth and depth of disease and condition content from a focused initiative to provide point-of-care coverage superior to UpToDate. With an expert staff of clinical editors, writers, and other contributors, DynaMedex not only offers the most evidence-based disease and condition content for point of care, but also delivers more extensive coverage of specialty topics than any other evidence-based decision support resource.

DynaMed Editor in Chief, Peter Oettgen MD, FACC, FAHA, FACP says that the DynaMedex resources offer a streamlined experience for clinicians looking to gain access to reliable, current information. In todays world of rapidly changing medical information and increasing burdens placed on healthcare professionals, DynaMedex aims to provide first class evidence and guidance. Clinicians requested that DynaMedex content expand to cover all diseases and conditions in UpToDate. With this expanded disease and condition content, together with the integration of differential diagnosis, shared decision-making tools and access to robust drug delivery content, clinicians benefit from a unique, integrated solution that meets all their needs. Clinicians can be confident they have the most current and potentially-practice changing evidence across clinical topics. Adding SMART on FHIR integration to this content creates an even more powerful, efficient experience.

DynaMedex disease and condition content is designed to provide the best available evidence, enhance the clinician/patient relationship, and streamline clinician workflows, leading to better patient and health system outcomes. On the heels of DynaMedex disease content being named 2022 Best in KLAS for Clinical Decision Support for the second consecutive year, and receiving the Frost & Sullivan 2022 North America Product Leadership award, DynaMedexs team of clinical experts continues to push toward improved clinical outcomes through a combination of new tools, an enhanced user experience, streamlined EHR integrations, and an industry-leading depth and breadth of content.

Supported by powerful search technology, DynaMedex quickly identifies and surfaces information and tools to shorten time from question to answer. DynaMedex disease contents SMART on FHIR integration brings secure, universal access to the EHR.

For clinicians looking to gain access to the best disease and condition evidence, differential diagnosis algorithms, shared decision-making tools, and robust drug evidence content in a streamlined experience, DynaMedex is now among the highest quality and most comprehensive clinical decision support offerings worldwide.

To learn more about EBSCOs Clinical Decisions suite of products, visit: http://www.clinicaldecisions.com.

About DynaMedex DynaMedex is a solution for clinical care teams that combines DynaMed disease evidence from EBSCO Information Services (EBSCO) and Micromedex drug evidence from Merative. Learn more at dynamedex.com.

About EBSCO Information Services EBSCO Information Services (EBSCO) is the preeminent provider of online research content and search technologies serving academic, school and public libraries; healthcare and medical institutions; corporations; and government agencies around the world. EBSCOs Clinical Decisions suite of products are designed to improve patient care by providing healthcare professionals with the most current, evidence-based answers to clinical questions as they arise at the point of care. For more information, visit the EBSCO website at:http://www.ebsco.com.

###

For more information, please contact: EBSCO Information Services Communications Team mediainquiries@ebsco.com

UpToDate is a registered trademark of Wolters Kluwer.